Brian Best

Background

About Brian Best

Thirty-four years of operational experience in large and small pharmaceutical, device and diagnostic companies, serving in a variety of senior leadership roles. Presently: Board Member, Biomeme, Inc. Recently: Co-Founder and CEO of Predigen, a Duke University precision medicine start-up leveraging host gene expression to predict and manage health and disease (acquired by Biomeme, Inc.); Co-Founder and CEO of Ariste Medical, a commercial-stage company developing drug eluting implantable medical devices; and President of BestBio Consulting, providing strategic advisory services to senior management in various healthcare markets. Specialties: commercial leadership; business development, licensing and acquisition; registry and study design, development and execution; medical affairs, marketing, and sales force development and optimization; organizational growth and development; strategic planning; drug, device, and diagnostic development.